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Recent studies suggest a role for Th17 responses in the
increased airway neutrophilia associated with severe
asthma. House dust mite (HDM) is a natural allergen to
which asthmatics are often sensitized. Mice repeatedly
challenged with HDM extract developed robust airway
neutrophilia rapidly evolving into asthma-like disease
with increased numbers of eosinophils and lymphocytes
in bronchoalveolar lavages (BAL) as well as inflamma-
tory infiltrates, vascular/muscular hypertrophy, inter-
stitial fibrosis, epithelial hyperplasia and mucus
accumulation in lung tissues. RNA and protein screen-
ing revealed a robust Th17 component post-HDM expo-
sure. We thus evaluated whether IL-17A deficiency
could modulate HDM-induced allergic airway disease.
Airway neutrophilia was indeed abrogated in IL-17A
deficient mice weekly challenged with HDM (acute
model), however total BAL cellularity and lung
mechanics remained comparable to those of HDM-chal-
lenged WT mice. In contrast, IL-17A deficient mice
daily exposed to HDM (chronic model) had decreased
BAL cellularity associated with reduced numbers of BAL
macrophages, neutrophils, eosinophils and lymphocytes.
Interestingly antibody neutralization of TL1A, a member
of the TNF superfamily known to promote Th2 and
Th17 responses, reduced BAL cellularity to baseline
levels in HDM-challenged WT mice. Our results thus
indicate that targeting Th17 responses can alleviate
HDM-induced airway neutrophilia, and can also broadly
modulate allergic airway disease.
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